Collaborative effects of wavefront shaping and optical clearing agent in
  optical coherence tomography by Yu, Hyeonseung et al.
1 
Collaborative effects of wavefront shaping and optical clearing agent in optical 
coherence tomography 
 
Hyeonseung Yu,a,f Peter Lee,b,f YoungJu Jo,a,f KyeoReh Lee,a,f Valery V. Tuchin,c,d,e Yong Jeong,b,f 
YongKeun Park a,f,* 
aDepartment of Physics, Korea Advanced Institute of Science and Technology, Daejeon 34141, South Korea 
bDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, South Korea  
cResearch-Education Institute of Optics and Biophotonics, Saratov National Research State University, 83, Astrakhanskaya Street, 
Saratov 410012, Russia 
dInstitute of Precision Mechanics and Control of Russian Academy of Sciences, Saratov 410028, Russia 
eLaboratory of Biophotonics, National Research Tomsk State University, Tomsk 634050, Russia 
fKAIST Institute of Health Science and Technology, Daejeon 34141, Republic of Korea 
Abstract. We demonstrate that simultaneous application of optical clearing agents (OCAs) and complex wavefront shaping in optical 
coherence tomography (OCT) can provide significant enhancement of the penetration depth and imaging quality. OCA reduces optical 
inhomogeneity of a highly scattering sample, and the wavefront shaping of illumination light controls multiple scattering, resulting in 
an enhancement of the penetration depth and signal-to-noise ratio. A tissue phantom study shows that concurrent applications of OCA 
and wavefront shaping successfully operate in OCT imaging. The penetration depth enhancement is further demonstrated for ex vivo 
mouse ears, revealing hidden structures inaccessible with conventional OCT imaging. 
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1 Introduction 
  Developing a deep-tissue imaging tool with good optical resolution is one of the important goals of biophotonics 
because medical diagnosis usually requires imaging of fine details of whole tissue structures. Optical coherence 
tomography (OCT) is an extensively developed imaging tool for biological tissues. Based on low-coherence 
interferometry, OCT provides micrometer scale resolution and enables non-invasive high-speed imaging1. OCT 
is widely used in ophthalmology because it can fully access retina, choroid and sclera layers of human eyes in 
vivo.2, 3 OCT has a higher penetration depth of 12 mm compared to other optical imaging modalities such as 
multi-photon microscopy and confocal microscopy.4 Photoacoustic microscopy also offers deep tissue imaging 
capability but optical absorption contrast is used instead of elastic backscattering signals5. Despite its advantages, 
OCT cannot provide penetration depth on centimeter scales, as is possible with ultrasound imaging.  
  The limitation of the penetration depth of OCT originates from multiple light scattering caused by 
inhomogeneous refractive index distributions in biological tissues. The strategy of OCT imaging is to deliver light 
deep into a target region and measure backscattered light. However, light is severely scattered during propagation 
inside a biological tissue. Biological tissues are composed of various cellular components, each having different 
chemical compositions and thus different refractive indices. For example, cellular organelles, cytoplasm, and 
collagen fibers have refractive indices higher than that of interstitial fluid. More quantitatively, optical waves 
have a reduced scattering coefficient of about one mm-1 in most biological tissues.6 This implies that after 
propagation of 1 mm, the light experiences a few scattering events (on average ten for the scattering anisotropy 
factor typical for tissues, g = 0.9), after which the light completely loses its original propagation direction. To 
minimize the effect of multiple scattering events, OCT uses coherence gating to collect scattering signals 
selectively with the same optical path lengths. However, the amount of single scattered light exponentially decays 
as the depth increases, and the multiple scattering becomes dominant beyond a few mean free paths.7  Thus, it is 
extremely challenging to image scatterers at depths greater than approximately 1 mm; thus, penetration depth is 
limited to a few millimeters.  
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One method of visualizing deep inside tissues in OCT systems is to utilize optical clearing agents (OCAs) to 
compensate for optical inhomogeneity.8, 9 The primary role of OCAs is to reduce refractive index mismatches 
among tissue structures and thus to reduce light scattering in the tissues.10-12 Due to the complexity of tissue 
structures, the reduction of the scattering cannot be explained merely by the refractive indices of the OCAs13, 14. 
In fact, various mechanisms are involved, such as the dissociation of collagen15, 16, the ability to disrupt the 
hydration shell and the water-mediated hydrogen bonds of collagen molecules,17 and the dehydration process10, 
18-20. In addition to penetration depth enhancement for tissue imaging21-23, OCAs also enable optical blood clearing 
24 and monitoring of molecular diffusion25-30 using OCT systems. 
Whereas OCA approaches use the scattering properties of tissue samples for the enhancement of the penetration 
depth, it has been recently demonstrated that controlling the illumination light in optical imaging can offer a high 
possibility of overcoming multiple scattering without affecting the sample. Although adaptive optics approaches 
were exploited to correct aberrations, the multiple light scattering requires more degrees of freedom31, 32. The 
formation of optical focus can be interpreted as constructive interference of scattered light waves. Multiple light 
scattering scrambles phase information of an impinging beam, and thus the desired constructive interference, or 
optical focus, cannot be achieved deep in a tissue. However, these perturbations can be adjusted by controlling 
the complex field of the incident light 33, 34. This idea was first demonstrated by showing that clear optical focus 
can be formed through highly scattering media35; later, this wavefront shaping approach was extended to optical 
systems that are based on OCT principles. The focusing of light into deep tissue was demonstrated using optical 
coherence microscopy36, and penetration depth enhancement was studied in a spectral domain OCT system37-39, 
the so-called wavefront shaping OCT (WS-OCT). The measurement of a time-resolved reflection matrix based 
on the principles of time-domain OCT enabled selective focusing inside tissues40 and diffraction-limited 
imaging41, 42. In a related field, wavefront shaping approaches have also been exploited for deep-tissue imaging 
with multi-photon microscopy43, 44. One of the advantages of using wavefront shaping in OCT is that the light 
control can also compensate system aberrations or the degradation in resolutions at out-of-focus planes45.  
  In this work, we demonstrate that simultaneous applications of wavefront shaping and optical clearing agents 
can provide collaborative effects for enhancing penetration depth using WS-OCT. Even though both the 
wavefront shaping and OCAs enhance the penetration depth, the collaborative effect is not straightforward due 
to the loss of the scattering contrast by OCAs.  Because the wavefront shaping technique utilizes the backscattered 
signals for the optimization, the reduced scattering by OCAs should be still strong enough so that the wavefront 
shaping works. A tissue-mimicking phantom and an ex vivo mouse ear tissue were visualized with the application 
of 70% glycerol solution and wavefront shaping via a digital micro-mirror device (DMD). Benefitting from 
balanced applications of the OCAs and the wavefront shaping, collaborative effects of both methods offer 
unprecedented enhancement of the penetration depth compared to that possible with conventional spectral domain 
OCT (SD-OCT) imaging.    
2 Principles 
The principles of OCA and wavefront shaping in OCT are illustrated in Fig. 1. In a conventional OCT system, an 
uncontrolled beam is incident on a sample and backscattered signals from a scatterer are used as image contrast. 
The desired situation is one in which a tight focus is formed at a target axial depth and signals are strongly 
reflected from the focus, providing vivid images of tissue structures. However, due to optical inhomogeneity 
inside the tissue, the beam propagation paths that are supposed to be focused on the target spot experience spatially 
varying perturbations. 
This situation leads to severe degradation of the optical focus, as illustrated in Fig. 1(a). There are two different 
approaches that can alleviate this degradation of the focus: the application of OCA, as shown in Fig. 1(b), and 
wavefront shaping, as shown in Fig. 1(c). In Fig. 1(b), OCA can be seen to reduce the inhomogeneity of the tissue, 
and the multiple scattering becomes less severe. The penetration depth can be extended at the expense of the 
tissue composition change. In contrast to the OCA approach, which directly changes the sample, the wavefront 
shaping method controls light propagation in tissues to maximize the light delivery to scatters and the reflection 
from the scatters, as shown in Fig. 1(c). Because the wave-propagation in tissues is a deterministic process, we 
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can find an optimal wavefront that can selectively focus at the target depth inside the tissue. While the OCA 
directly suppresses multiple light scattering by manipulating the tissue, wavefront shaping controls the light paths 
without affecting the tissue structure. Therefore, these two approaches can work concurrently, and the 
combination of both methods provides collaborative effects to control multiple light scattering. This best situation 
of the combined approach is illustrated in Fig. 1(d). For all the above cases, the enhancement of the penetration 
depth can be maximized when the OCA technique and the wavefront shaping approaches are simultaneously 
applied.  
 
3 Experimental Setup 
A schematic of the experimental setup is shown in Fig. 2. The system was adapted from an SD-OCT system by 
incorporating high-speed wavefront modulation37. In a conventional system, a collimated beam from an 
illumination source directly passes through a beam splitter and the divided beams arrive incident on a sample and 
a reference mirror, respectively. For the wavefront shaping OCT (WS-OCT), a wavefront shaping unit consisting 
of a digital micro-mirror device (DMD) and a dispersion compensating grating (G1) is additionally installed, as 
indicated by the gray dashed rectangular area. After the wavefront shaping unit, OCT signals are acquired and 
processed based on SD-OCT principles. Detailed theories on SD-OCT systems can be found in the literature45.  
In the WS-OCT system, a broadband superluminescent diode (SLD-52, Superlum Diodes, Ltd., Ireland) with a 
center wavelength of 1025 nm (full width at half maximum = 100 nm, 9.7 mW) is used as the light source. The 
beam propagates in free space after the collimator and impinges on the DMD (0.7 XGA, 1024768, Texas 
Instruments, United States). The DMD is a 2-D array of 800K micro-mirrors; each mirror directs the incident 
beam at 12 or -12. The light redirected from the DMD with the angle of 12 propagates along the optical axis; 
the light redirected with the angle of -12 is blocked out. Thus, the control of individual micro-mirrors provides 
spatially structured incident beams. Due to the pixelated periodic structure, the DMD essentially works as a 
grating. For broadband illumination, the dispersion is produced and therefore is compensated for by the grating 
(300 lines/mm, GR25-0310, Thorlabs, United States). The modulated field pattern is delivered to the back pupil 
of an objective lens (LSM-03BB, Thorlabs, United States) through two 4-f systems. The modulated incident beam 
is divided into a sample beam and a reference beam at the beam splitter, and then the reflected light from the 
sample and the mirror are collected by a single mode fiber. At the output facet of the collection fiber, interference 
signals of the sample and reference beams are analyzed by a spectrometer system consisting of a grating (1200 
lines/mm, Wasatch Photonics, United States) and a line CCD (SU1024, 1024 lines, 92 kHz frame rate, Sensors 
Unlimited Inc,. United States). A 2-D image is acquired by steering the sample beam with one mirror of a 2-axis 
glavo mirror (6210H, Cambridge Technology, United States) while the other mirror is unused. Because the DMD 
plane is conjugated with the scanning mirror plane, the amplitude modulation at the DMD plane is converted to 
full-field modulation at the sample plane. In the setup, the reference beam is also modulated by the DMD in order 
to preserve the simplicity of the setup. It is possible in principle to separate the reference beam and sample beam, 
but matching the optical path lengths between the separated sample and reference beams requires more 
complicated setup. We also considered that simultaneous modulation of both arms does not result in the difference 
in the acquired signal, because the interference signal is a function of the temporal frequency, whereas the DMD 
modulates the spatial profile of the incident beam. The spatial modulation of the reference beam only changes the 
coupling efficiency to the single mode fiber, which is calibrated in the signal processing step. 
  The goal of wavefront shaping optimization is to maximize the reflected signal from the desired depth. Because 
tissue compositions are entirely unpredictable, characterization of the optical responses of the tissues is required 
to find the optimal wavefront. Furthermore, tissue structures vary spatially. Thus, the optimization is sequentially 
processed for each A-scan. In the optimization of a single A-scan, the detailed procedures are divided into three 
stages: 1) recording of OCT signals with Hadamard pattern projections to characterize the tissue response, 2) 
calculation of optimal DMD patterns, and 3) recording of enhanced signals for projections of optimal DMD 
patterns.  
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At first, 7,500 2-D Hadamard patterns are sequentially projected on the DMD and A-scan profiles are recorded 
for each pattern. Hadamard patterns are mutually independent, and this property minimizes the redundancy of the 
image acquisitions. Second, we select 200 depth positions as regions of interest (ROI) in the A-scan and 
individually calculate the optimal pattern at each depth. Here, the axial resolution is 2.9 µm and 200 pixels ROI 
corresponds to a 580 µm depth range. In the calculation of the optimal DMD pattern at a specific depth, we 
selectively choose 500 Hadamard patterns out of the 7,500 initial patterns that give the largest signal at the given 
depth. Because the coherent control of light scattering exploits the linear relation between the input and reflected 
light fields, raw signals are manipulated in a linear scale. After that, we coherently sum the selected 500 patterns 
to produce a single optimal pattern. Consequently, we have a total of 200 optimal patterns that individually 
generate the optimal signal at each depth of the ROI. Third, the calculated 200 optimal patterns are projected 
sequentially on the DMD, and the enhanced OCT signals are recorded. The recorded 200 A-scan signals contain 
the enhanced signals at different depth positions, so they are compounded into a single A-scan image in which all 
pixels in the ROI have the enhanced signal. The acquisition time of a single optimized A-scan image is 15 seconds, 
and 25 A-scans are acquired to obtain a 2-D image. 
To demonstrate the coherent control effect of the wavefront shaping, we also acquired the images using the 
spatial compounding method, which provides a way of suppressing coherent speckle noises by incoherently 
averaging several OCT signals from spatially- or temporally-varying illuminations46-49. In our case, 25 random 
binary DMD patterns were illuminated on the sample, and the 25 acquired OCT signals were incoherently 
summed to reduce the noise. To properly compare the spatial compounding method and the wavefront shaping, 
the size of the macro-pixels in the DMD and the camera acquisition settings are set to be the same for both cases.  
 
4 Tissue phantom Study 
To validate the idea of the combined effect of OCA and wavefront shaping for the penetration depth enhancement, 
we first conducted experiments on a tissue phantom fabricated with 20% intralipid and agar50. Among various 
tissue phantom models 51, the used phantom has several advantages: 1) the good permeability of agarose enables 
the efficient diffusion of OCAs, 2) the scattering coefficient of the tissue phantom is easily tuned by changing the 
weight/volume fraction of the intralipid 
4.1 Sample preparation 
For the fabrication of the tissue phantom, agarose solution is first prepared by dissolving 1 g of agarose powder 
(A5304-100G, Sigma-Aldrich, United States) in 100 ml of distilled water at 95ºC. Then, 20% intralipid (Fresenius 
Kabi AB, Sweden) and agarose solution are homogenously mixed at a 2% weight/volume fraction at 75ºC. After 
the temperature of the mixture reverts to room temperature, the mixture becomes a solid state spontaneously. The 
reduced scattering coefficient of the tissue phantom is measured and found to be 1.210.13 mm-1; this value is 
obtained by integrating the sphere measurement and inverse-adding doubling methods 52. Most biological tissues 
have the reduced scattering coefficients of approximately one mm-1, which is comparable to the value of the 
fabricated tissue phantom 6. We note that the scattering properties of the use tissue phantom are not identical to 
those of biological tissues. The anisotropy factor of intralipid is 0.52 at 1064 nm wavelength53. In general, 
biological tissues have anisotropy factors of 0.8—1.0.6 Glycerol, a 70% solution in water, was used as an OCA. 
The refractive indices of intralipid and agarose are 1.35753  and 1.334854 at 1064 nm, respectively. From the law 
of Gladstone and Dale, the mean refractive index of the tissue phantom is estimated as 1.3392. The scattering 
particles in intralipid are soybean oil, and its refractive index is 1.46012. When the glycerol with the RI of 1.463 
is applied to the tissue, it is expected to match the refractive indices of the background and soybean oil by 
increasing the refractive index of the background. 
The target imaging sample has a layered structure: layer I is the tissue phantom, layer III is a translucent petri 
dish and the layer II is the boundary between layer I and layer III, as shown in Fig. 3(a).  
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4.2 Experimental results 
To demonstrate the effect of the OCA and the wavefront shaping, we compared wavefront shaping and 
conventional images of the tissue phantom before applying OCA and after applying OCA. A photograph of the 
sample before the application of the OCA is shown in Fig. 3(b). The tissue phantom layer is fabricated to have a 
slope so that the left part is thinner than the right part. Due to the small thickness, the left part looks more grayish 
than the right part, but there is still a clear difference in the color between the left part of the sample and the petri 
dish. When the OCA was applied to the left thinnest part, reduction in scattering made the layer almost transparent, 
and the petri dish below became visible, as shown in Fig. 3(c). This clearing effect is more clearly visible in the 
insets with the magnified images of the edge. Before applying the glycerol OCA, the wavefront shaping and 
uncontrolled illumination results are acquired as depicted in Figs. 3(d-g). The imaging region is set to be around 
the red dashed circle in Fig. 3(b). Fig. 3(d) shows an image with wavefront shaping; Fig. 3(e) shows an image 
acquired using uncontrolled illumination; Fig. 3(f) is an image acquired using the spatial compounding method. 
The images of Figs. 3(d-f) were all acquired from the same incident beam power of 0.55 mW. The images obtained 
using the uncontrolled illumination and spatial compounding methods show similar penetration depths and signal 
levels, but we can see that these two conventional imaging methods have large shortcomings compared to the 
wavefront shaping method regarding penetration depth and signal to noise ratio (SNR). For further comparison, 
the image in Fig. 3(g) was acquired using uncontrolled illumination but with doubled incident power of 1.1 mW. 
The wavefront shaping image shows a comparable level of SNR and even slightly more features below layer II 
compared with the sample subject to doubled power illumination. To quantitatively compare the signal levels for 
the four cases, we plotted the averaged signal profiles over 25 A-scans versus depth. We can see that wavefront 
shaping yields the largest signal over the depth ranges. The signal levels exponentially decay as the depth 
increases, so layer I is the only accessible imaging area even in wavefront shaping.  
  After demonstrating the enhanced penetration depth with wavefront shaping in the original sample state, we next 
applied the OCA to the same region and acquired images with the same procedures as used above. After adjusting 
only the z-position of the sample stage, we applied 300 µl of 70% glycerol solution to the imaging region and 
restored the sample to the original position. We waited for 10 minutes after the application of the OCA to allow 
OCA to diffuse into the sample. A wavefront shaping image acquired after the OCA is shown in Fig. 3(i). The 
third layer became visible; it had not been possible to visualize this layer using any of the previous methods. Also, 
the signal level decreased in the phantom layer, which implies that the OCA successfully penetrated into the tissue 
phantom and made the sample more transparent. This effect can also be observed in the uncontrolled beam image 
and the spatial compounding image, as shown in Fig. 3(j) and 3(k), respectively. Since the scattering of the 
phantom sample is significantly reduced, no meaningful signal having structural information is observed in layer 
I. Fig. 3(l) shows an image acquired using double powered uncontrolled illumination.  
  The average profiles over 25 A-scans are plotted in Fig. 3(m). Compared to the signal profiles obtained before 
the OCA, the signal level has decreased in layer I and the signals from the petri dish in layer III have increased 
against the background signal level. Without the OCA, the maximum penetration depth for wavefront shaping is 
less than 300 µm, as can be seen in Fig. 3(h). With the OCA and wavefront shaping, structures deeper than 600 
µm from the surface became accessible, as can be seen in Fig. 3(m), which shows a more than two-fold 
enhancement in the penetration depth.  
5 Ex vivo mouse ear 
To test the suitability of our technique for real biological samples, we next applied the OCA and wavefront 
shaping to an ex vivo mouse ear. In the tissue phantom study, the optical inhomogeneity of the petri dish was not 
affected by the application of the OCA, and these preserved scattering contrasts were easily imaged using WS-
OCT. For real biological samples, however, all imaging regions are optically cleared by the OCA. Therefore, it 
is important to confirm the proposed technique in real biological tissues.  
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5.1 Sample preparation 
After anesthetization with an intraperitoneal injection of Tiletamine-Zolazepam and Xylazine mixture (30:10 
mg/kg body weight), a mouse ear was dissected from a specific pathogen-free C57BL/6J mouse (Jackson 
Laboratory, U.S.A.). All experimental procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of the Korea Advanced Institute of Science and Technology (KAIST). After the dissection, 
the ear was immersed in 70% glycerol solution for an hour. A photograph of the whole mouse ear is shown in 
Fig. 4(a); the representative histology of the sub-region is shown in Fig. 4(b). To compare the histology and the 
OCT images, subsequent OCT signals are plotted according to physical depth while assuming a refractive index 
of 1.4 for the mouse skin 6. For example, a 140 μm optical depth in OCT signal is converted to a 100 μm physical 
depth. This scale factor can vary upon the application of OCAs. Since the refractive index of 70% glycerol is 
1.463, the change in the scale factor is less than 5% even under the assumption that the sample medium is 
completely replaced with glycerol. This change corresponds to the 12 μm for a 300μmthickness sample. Thus 
we assume there is no significant effect of the OCA on the comparison between the histology and the OCT images.  
 
5.2 Experimental results and Discussion  
Three different locations on the mouse ear were imaged before OCA, and three other locations were imaged after 
the application of OCA. The OCT images before OCA are first presented in Figs. 4(c-h). For clear comparisons, 
we show here only the wavefront shaping images and the uncontrolled beam images for the same incident power 
of 0.55 mW. The wavefront shaping images [Figs. 4(c,e,g)] show superficial layers of the ear tissue, while image 
signals cannot be clearly seen with the uncontrolled beam illumination, as shown in Figs. 4(d,f,h). Although 
wavefront shaping provides enhanced penetration depth and SNR over those characteristics of uncontrolled beam 
illumination, only a single layer is visible, and the structural information of the ear is hardly attainable even in 
the wavefront shaping case.  
  To achieve more enhancement of the penetration depth using OCA, we immersed the ear in the 70% glycerol 
solution and acquired OCT images, which are shown in Figs. 4(i-n). Since the whole ear was taken off of the 
sample stage and immersed in the OCA solution, locating the original imaging positions was impossible, so we 
assumed that the penetration depth was constant for nearby imaging areas. As can be clearly seen in Figs. 4(i,k,m), 
the wavefront shaping technique provides remarkable enhancements: the double layered structures can be 
visualized for every location. For the uncontrolled input beam cases [Figs. 4(j,l,n)], the signal strengths are slightly 
better than those acquired before the OCA, but still they provide blurred images of the tissue structures.  
  Figure 4(b) provides a representative histology image taken from the middle ear of a mouse that may reflect the 
multilayer structure found in Fig. 4(i,k,m). It should be noted that the histology and OCT images were acquired 
from different ears. However, we assumed that the general structure is about the same in ears of the same species. 
In particular, for the case shown in Fig. 4(i), we speculate that the three layers (I, II,III) match the epidermis, 
auricular cartilage, and smooth muscle, as found in Fig. 4(b).  
  To compare these data quantitatively, we plotted the averaged depth profiles over 25 A-scans in Figs. 5(a-f) for 
each location, as can be seen in Fig. 4. The same trends as those found in the cases of the tissue phantom study 
are observed: 1) wavefront shaping gives the highest signal level in all locations, 2) the uncontrolled beam 
illumination with 0.55 mW and the spatial compounding method with 0.55 mW give the smallest SNR. When the 
wavefront shaping cases are considered exclusively, imaging depths are limited up to approximately 200 µm 
before the OCA and the penetration depth reaches about 300 µm after applying the OCA. 
  The results above clearly show the collaborative effects of wavefront shaping and OCA in OCT. Using scattering 
phantom samples and in-vitro biological tissue samples, we have demonstrated that both the penetration depth 
and the signal-to-noise ratio can be significantly improved, compared to the case of using conventional OCT 
without OCA treatment. Importantly, the simultaneous application of wavefront shaping and OCA results in 
collaborative effects for deep-tissue optical imaging.  
  For future studies, the optimal conditions of the OCA treatment and wavefront shaping should be further 
investigated. For example, various optical clearing agents are available for different tissues types and imaging 
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conditions.19, 55, 56 The optimal selection of OCAs will provide more enhanced penetration depths. The wavefront 
shaping technique also has much room for improvement. In our previous results 37, the depth enhancement factor 
increases as the scattering of the tissue phantom is reduced. This trend shows a positive sign that further 
optimization of collaborative effect can lead to the synergetic effect of the both method, where the depth 
enhancement is greater than the sum of individual effects. Although we focused on the reduced scattering 
coefficient of the sample, the effects of the variation on the anisotropy factor and the scattering coefficient is still 
an open question. Proper setting of the wavefront parameter according to the sample conditions is expected to 
bring about higher enhancements of the penetration depth. 
 In the current approach, there is partial loss of sample information due to OCAs, as seen in the optical clearing 
of the phantom layer in the tissue phantom study. Furthermore, there should be balanced applications of OCAs. 
The wavefront shaping utilizes backscattered signals as a feedback signal. Thus the reduction of scattering can 
prevent efficient wavefront shaping. For example, the complete clearing of OCAs makes the present approach 
inapplicable. The minimum amount of scattering for collaborative effects should be further studied.  
  The ultimate goal of deep-tissue imaging is to achieve penetration depth enhancement in vivo23, 57, 58. We 
anticipate that in vivo application can be realized in the near future because OCA and WS-OCT have worked 
successfully in in vivo environments. However, many experimental difficulties have to be overcome. First, the 
delivery of the OCA into living tissues is not straightforward and usually requires special treatments.21, 59 Second, 
the image acquisition speed with wavefront shaping must be further optimized. Recently, we demonstrated that 
the wavefront shaping OCT works for static biological tissues in vivo39. However, the 15-second optimization 
time for a single A-scan is too slow to image moving tissues. To be applicable for in vivo imaging, the wavefront 
shaping should be fast enough as the aberration correction in sensorless adaptive optics OCT60, 61. To enhance the 
optimization speed, various approaches can be applied, such as the computation time reduction using graphics 
processing unit (GPU), implementing the wavefront shaping in swept-source OCT platform or designing efficient 
optimization algorithm based on pre-acquisition plain OCT data. If these problems are adequately addressed, 
wavefront shaping and OCAs will provide a promising method for in vivo deep-tissue imaging. 
6 Conclusion 
Here, we have demonstrate penetration depth enhancement in WS-OCT by simultaneously using wavefront 
shaping and OCAs. With the application of 70% glycerol solution as an OCA and the wavefront shaping technique 
via a DMD, we visualized multi-layered structures of a tissue phantom and ex vivo mouse ear with unprecedented 
penetration depth enhancement in comparison to that possible with conventional OCT imaging. For the image 
optimized with wavefront shaping, the application of OCA provided an additional enhancement factor of 1.5–2 
for the penetration depth. 
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Fig. 1 Principle of optical clearing agents and wavefront shaping in an OCT system. (a) Conventional OCT 
imaging. (b) After the application of OCAs, the overall scattering of the tissue is reduced. (c) Wavefront shaping 
in OCT. The optimal incident wavefront generates a tight focus inside the tissue. (d) Combined effect of OCAs 
and wavefront shaping. Maximal penetration depth can be achieved with reduced scattering of the sample and 
optimal incident light field. 
 
 
Fig. 2 Experimental setup. Gray dashed rectangular area: wavefront shaping unit: SLD - super-luminescent diode, 
DMD - digital micro-mirror device, G1 - dispersion compensating grating; BS - beam splitter, DC - dispersion 
compensator, GM - galvo mirror, G2 – spectral OCT grating; C – collimators, L - lenses, M - mirrors, SMF – 
single mode fiber. The intensity modulation after the DMD is not to scale. 
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Fig. 3 (a) Structure of a tissue phantom. Photograph of the tissue phantom (b) before applying the OCA and (c) 
after applying the OCA. (inset) magnified views of the edges. (d-h) Images acquired before the OCA. (i-m) 
Images acquired after the OCA. (d,i) Optimized image obtained by wavefront control  with input power of 0.55 
mW. (e,j) Images acquired for an uncontrolled beam of 0.55 mW. (f,k) Images obtained by spatial compounding 
method. (g,l) Images acquired for uncontrolled beams of 1.1 mW. (h,m) The averaged A-scan profiles along 25 
A-scans were plotted for each method. 
 
 
Fig. 4 (a) Dissected mouse ear; (b) histology of the ear; (c-h not shown) images acquired before the OCA; (i-n 
not shown) images acquired after the OCA; (c,e,g,i,k,m not shown) image optimized by wavefront control with 
the input power of 0.55 mW at location 1-6; (d,f,h,j,l,n not shown) images acquired for uncontrolled beam of 0.55 
mW at locations 1–6.  
 
13 
 
 
Fig. 5 The averaged A-scan profiles along 25 A-scans for each method (a-c) before the OCA and (d-f) after the 
OCA at location 1–6.  
